Caitong International Asset Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Caitong International Asset Management's RXST Position: Q2 2026 in Review
Caitong International Asset Management increased its RxSight (RXST) stake by 487% in Q2 2026, buying an estimated $3.94K and bringing the position to 786 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.
Caitong International Asset Management first reported a position in RXST in Q4 2024 and has held it in 7 quarters since. The position peaked at $44.3K in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Caitong International Asset Management held 786 shares of RxSight worth $3.79K as of Q2 2026.
- Caitong International Asset Management bought 652 RxSight shares in Q2 2026, an estimated $3.94K.
- RxSight made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1321 holding.
- Caitong International Asset Management first reported a position in RxSight in Q4 2024 and has held it in 7 quarters since.
- Caitong International Asset Management's RxSight position peaked at $44.3K in Q4 2025.
- 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.